Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06070688 · ClinicalTrials.gov registry record · NA

An Adjunct Test Distinguishing Bacterial From Viral Etiology Improves Resource Utilization and Efficiency in the ED.

A NA study of Respiratory Tract Infections, sponsored by The University of Texas Health Science Center, Houston.

Recruiting
Registry status
NA
Development phase
100
Enrollment target
1
Study location

NCT06070688: Recruiting NA study of Respiratory Tract Infections, sponsored by The University of Texas Health Science Center, Houston.

NCT06070688 is a NA study of Respiratory Tract Infections that is actively recruiting participants, run by The University of Texas Health Science Center, Houston. The registered enrollment target is 100 participants, below the 2,768-participant average among 15 other Respiratory Tract Infections trials with a reported enrollment target (96% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06070688, a NA study of Respiratory Tract Infections, is actively recruiting participants, sponsored by The University of Texas Health Science Center, Houston.

RECRUITING
Registry status
NA
Development phase
100 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to evaluate overall changes in patient management and longer-term resource utilization between control and test arms, including (but not limited to) additional work-up (including other diagnostic tests and consults), antimicrobial treatments, disposition decisions and hospital length of stay (LOS)

Primary Outcome

Additional diagnostic tests may include serial complete blood count (CBC)s, additional blood cultures, viral cultures and serial basic metabolic panel (BMP) blood bank

Interventions

  • DIAGNOSTIC_TEST MeMed BV® biomarker test
  • DIAGNOSTIC_TEST Usual care

Study Locations (1)

Texas

  • The University of Texas Health Science Center at Houston - Houston

Trial Details

FieldValue
Enrollment Target 100 participants
Start Date 2023-12-11
Est. Completion 2026-12-31
Phase NA

What NCT06070688 shows while recruiting

NCT06070688 is an interventional study that assigns participants to a tested intervention. The registered 100 participants enrollment target is mid-sized for trials with a published cap, below the 2,768-participant average among 15 other Respiratory Tract Infections trials with a reported enrollment target (96% lower).

The record links to 1 condition, with Respiratory Tract Infections appearing as the primary indexed condition, and to 2 interventions - of which MeMed BV® biomarker test is the first listed.

NCT06070688 reports a single indexed study location in Texas.

Frequently Asked Questions

What is clinical trial NCT06070688 about?

NCT06070688 is a clinical study titled "An Adjunct Test Distinguishing Bacterial From Viral Etiology Improves Resource Utilization and Efficiency in the ED.". The purpose of this study is to evaluate overall changes in patient management and longer-term resource utilization between control and test arms, including (but not limited to) additional work-up (including other diagnostic tests and consults), antimicrobial treatments, disposition decisions and ho...

What is the current status of trial NCT06070688?

This trial is currently recruiting. It is a NA study. The enrollment target is 100 participants. The study started on 2023-12-11. Estimated completion is 2026-12-31.

What conditions does trial NCT06070688 study?

This clinical trial studies the following conditions: Respiratory Tract Infections.

What interventions are being tested in trial NCT06070688?

The interventions under investigation include: MeMed BV® biomarker test (DIAGNOSTIC_TEST), Usual care (DIAGNOSTIC_TEST).

Who is sponsoring clinical trial NCT06070688?

This trial is sponsored by The University of Texas Health Science Center, Houston, which has 732 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06070688 being conducted?

This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Respiratory Tract Infections

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT06070688's enrollment target sits among peer trials

100 13th of 15 higher than 3 of 15 other Respiratory Tract Infections trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Respiratory Tract Infections trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01048281 · 100 participants

    Clinical & Pathological Studies of Upper Gastrointestinal Carcinoma

  • NCT01161199 · 100 participants

    The Use of Leukapheresis to Support HIV Pathogenesis Studies

  • NCT01327690 · 100 participants · Early Phase 1

    Mental Health in Veterans and Families After Group Therapies

  • NCT01730781 · 100 participants

    Imaging Cannabinoid Receptors Using Positron Emission Tomography (PET) Scanning

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06070688, the US trial registry maintained by the National Library of Medicine. NCT06070688 (mid enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.